$NVAX Coronavirus Pop May Be Rolling Over AlreadyNVAX
The "inevitability bell" may be starting to ring on this one. We called it short a few days ago -- and 7% higher. And now we may be seeing this start to play along. If short with us here, stops should be set in place in the $8.75 area to fence off the unbounded squeeze risk.
NVAX trade ideas
Novavax Coronavirus StockNovavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. Its vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
$NVAX Elevates on Wuhan Fever.. But Will it Last?NVAX
NVAX breaking out as a notable "Wuhan Coronavirus" play after company hit the wires with dev plan for vaccine candidate.
But the company has a history of under-delivering in key moments. This is a momo headline play, but after the fever breaks, so will the stock.
NVAX coronavirus panic.NVAX coronavirus panic. Currently, several biotech shares rose significantly yesterday. The driving force is a fundamental fear of the coronavirus. NVAX is one of the potential candidates who can isolate and solve the problem. The fair value of NVAX stock is currently around USD 11.5. Technically, the stock price is in the right place. But what about panic? Is technology down there? ... Not sure. With braver target prices, the next upswing can be exploited. Let's start with the most basic target price rule. The target price is the sum of the closing value of the given trading time frame and the ATR of the two farthest moving averages measured at the closing values. Where can we be brave here? There to raise the timeframe to W1. In this timeframe, we generate a closing value ATR and this can give you a target price level. So if we calculate a target price using W1 ATR calculation, then the target price can be 33.6usd. A 231% increase from the current level. This analysis is highly speculative. But in panic it can easily work.
NAVXNVAX’s innovation outlook is neutral based on a current score of 55 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is neutral. Over the past 4 quarters NVAX beat earnings estimates 1 time. For more analysis and articles visit our website .
NVAX Bullish PennantThese are my thoughts and positions,
1. Appears that NVAX has opportunity for breakout as pennant matures
2. Price is trending healthily above 200 EMA.Price is also above and respecting the 50 EMA like they're in a long term committed relationship celebrating Valentine's day.
3. Notice the mid term higher lows signifying bullish strength
4.Support market structure at $2.10 -2.20 is displaying strength.
5. Profit Target One $4.2,
Stop-Loss $1.47
6. Bullish on NVAX and mid to long term trend continuation.
NVAX impulse wave is expected...NVAX impulse wave is expected. Based on W1 technical analysis, a very significant impulse wave may develop in the exchange rate. The pulse amplitude can reach 6 usd levels. As we have shaped our strategy for this impulse, we are moving along this. The correction of the resulting pulse wave correction is expected to be 5.66 usd. The yellow rectangular movement is lateral, followed by an increase. The second strong rising wave, albeit momentum, is far below the pulse wave characteristics. The acceleration of movement is indicated by the steeper ATR axis (purple line). The second target rate may be around 10 usd levels.